National Institute Of Tuberculosis And Lung Diseases — Clinical Trial Site

34 Registered trials

13 Currently recruiting

Organisation

National Institute Of Tuberculosis And Lung Diseases

Location

Warsaw, Poland

Identifier

ORG-100031468

Address

Ul. Plocka 26, 01-138, Poland

Departments

1st Department of Lung Diseases
3 Klinika Chorob Pluc i Onkologii
3 Klinika Chorób Płuc i Onkologii
32: III Klinika Chorob Pluc i Onkologii
Dept. of Molecular Diagnosis
I Klinika Chorób Płuc
II Klinika Chorób Płuc
III Klinika Chorob Pluc i Onkologii
III Klinika Chorób Płuc i Onkologii
Klinika Chorób Płuc
Klinika Pneumonologii i Mukowiscydozy
l Klinika Chorob Pluc
N/A
oncology
Pneumology and Cystic Fibrosis
POL004: III Klinika Chorob Pluc i Onkologii
Przychodnia Przykliniczna Instytut Gruźlicy i Chorób Płuc
Przychodnia Przykliniczna
Zaklad Genetyki i Immunologii Klinicznej

Clinical trials at this site (34)

Search interface

A Study with an active treatment to Assess the Long-term Safety of Weekly Intravenous Product in Subjects with Pulmonary Emphysema due to Al… Ended

2024-513962-20-00 Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficien 5 2016-07-14
A Controlled Study with an active treatment and a Placebo to Assess the Efficacy and Safety of Weekly Intravenous Product in Subjects with P… Ended

2023-510030-83-00 Pulmonary Emphysema due to Alpha-1-Antitrypsin Deficien 5 2014-01-29
A global study of volrustomig (MEDI5752) plus chemotherapy versus pembrolizumab plus chemotherapy for participants with metastatic non-small… Halted

2023-503298-39-00 Metastatic Non-Small Cell Lung Cancer (mNSCLC) 5 2024-06-13
Phase 2b Randomized, Double-Blind Study with Phage for CF Subjects with Pseudomonas Lung Infection Ended

2024-519856-94-00 Cystic fibrosis 4 2025-08-18
A study to test whether BI 1819479 improves lung function in people with idiopathic pulmonary fibrosis (IPF). Ended

2023-508395-11-00 idiopathic pulmonary fibrosis 4 2024-09-10
A study to test whether BI 1839100 improves cough in people with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis Ended

2023-510249-79-00 Progressive pulmonary fibrosis (PPF) 4 2024-09-10
A Study designed to evaluate the efficacy and safety of tiragolumab plus atezolizumab compared with placebo plus atezolizumab administered i… Ended

2023-506696-10-00 Non-Small Cell Lung Cancer 5 2024-06-18
Phase 2 study comparing SAR447537 to plasma-derived A1PI therapy for AATD emphysema Ended

2023-508084-76-00 Alpha-1 Antitrypsin Deficiency (AATD) Emphysema 4 2024-05-31
A study to find out whether BI 1015550 improves lung function in people with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) Ended

2024-512803-37-00 Progressive Fibrosing Interstitial Lung Diseases (PF-IL 5 2022-10-05
A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People with Cystic Fib… Ended

2024-517663-23-01 Cystic Fibrosis 4